Bispecific antibodies for cancer therapy

Immunotherapy
Nurit Hollander

Abstract

Bispecific antibodies, in contrast to conventional monoclonal antibodies, can bind simultaneously two different antigens. Taking advantage of this virtue, they are mostly designed for immune effector cell redirection to tumors and for radionuclide pretargeting to tumors. Bispecific antibodies of the first generation were produced by chemical cross-linking or cell-fusion technologies. More recently, the application of genetic engineering technologies gave rise to numerous formats of bispecific antibody fragments and whole IgG molecules. Because bispecific antibodies enable therapeutic strategies that are not possible with conventional monoclonal antibodies, they attract strong interest. Several bispecific antibody formats have already shown clinical efficacy in cancer patients, catalyzing efforts to translate the imaginative bispecific antibody concepts into effective therapies.

References

Jan 7, 2003·Nature Medicine·Peter J Hudson, Christelle Souriau
Feb 21, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Sharon CohenNurit Hollander
Sep 27, 2003·Methods : a Companion to Methods in Enzymology·Nicole A Doria-Rose, Nancy L Haigwood
Apr 24, 2004·Proceedings of the National Academy of Sciences of the United States of America·Ludger Grosse-HovestGottfried Brem
Apr 28, 2004·Trends in Biotechnology·Peter KuferPatrick A Baeuerle
Jun 10, 2004·Protein Engineering, Design & Selection : PEDS·Tove OlafsenAnna M Wu
Sep 24, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Esther AvinNurit Hollander
Jan 22, 2005·Acta Pharmacologica Sinica·Roland E Kontermann
Feb 3, 2005·International Journal of Cancer. Journal International Du Cancer·Patrick HoffmannPatrick A Baeuerle
May 27, 2005·Acta Pharmacologica Sinica·Jonathan S Marvin, Zhenping Zhu
Sep 10, 2005·Nature Biotechnology·Philipp Holliger, Peter J Hudson
Oct 6, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Edmund A RossiDavid M Goldenberg
Oct 11, 2005·Drug Discovery Today·Evelyn WolfPatrick A Baeuerle
Nov 10, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Habibe KaracayDavid M Goldenberg
Dec 2, 2005·Expert Opinion on Biological Therapy·Kyra A GeldermanArko Gorter
Dec 29, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·David M GoldenbergJean-François Chatal
Mar 22, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jean-François ChatalUNKNOWN French Endocrine Tumor Group
Apr 26, 2006·Proceedings of the National Academy of Sciences of the United States of America·Edmund A RossiChien-Hsing Chang
May 19, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Philipp KieweMichael Untch
Jul 26, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Sandra J StraussT Andrew Lister
Feb 3, 2007·Cancer Immunology, Immunotherapy : CII·Herbert RiechelmannMichael Schmitt
Mar 10, 2007·The Journal of Biological Chemistry·Dafne MüllerRoland E Kontermann
Oct 31, 2007·International Journal of Radiation Oncology, Biology, Physics·Christel LarbouretDavid Azria

❮ Previous
Next ❯

Citations

Mar 13, 2013·Proceedings of the National Academy of Sciences of the United States of America·Aran F LabrijnPaul W H I Parren
Nov 3, 2012·The Journal of Biological Chemistry·Bernd J WranikDan Eaton
Sep 1, 2012·Protein Engineering, Design & Selection : PEDS·R CastoldiC Sustmann
Jun 22, 2010·TheScientificWorldJournal·Patrick ChamesDaniel Baty
Jan 4, 2013·PloS One·Justin M ScheerRichard Vandlen
Feb 25, 2015·Journal of Clinical Pharmacology·Chetan Rathi, Bernd Meibohm
Dec 4, 2013·International Immunopharmacology·Yulia VugmeysterSheldon S Leung
Oct 16, 2012·Journal of Immunological Methods·Guoying JiangHélène Gazzano-Santoro
Jan 1, 2011·Annual Review of Chemical and Biomolecular Engineering·Eric T Boder, Wei Jiang
Mar 14, 2019·Protein and Peptide Letters·Desmond O Acheampong
Jan 14, 2017·International Journal of Environmental Research and Public Health·Lin-Yu YuXiao-Ping Chen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antibody Engineering

Antibody engineering technologies are constantly advancing to improve the clinical effectiveness of monoclonal and bispecific antibodies. Discover the latest research on Antibody Engineering here.

Related Papers

Expert Opinion on Drug Metabolism & Toxicology
Xiaoying ChenWei-Chiang Shen
Cancer Research
Patrick A Baeuerle, Carsten Reinhardt
Nature Reviews. Drug Discovery
Aaron L NelsonJanice M Reichert
The New England Journal of Medicine
Pierre MiossecVijay K Kuchroo
© 2021 Meta ULC. All rights reserved